Completed Genetics & Molecular Biology Cells, Biochemistry & Physiology

Towards a mechanistic understanding of RNA processing machines

In plain English

AI plain-English summary

Sleeping sickness parasites edit their own mitochondrial RNA using a molecular machine that has no counterpart in human cells. This editing process is essential for the parasite’s survival, yet scientists do not understand how the machine recognises its RNA substrates. The problem is urgent: trypanosomatid parasites cause sleeping sickness and Chagas disease, affecting millions in developing countries with limited treatment options. Current drugs are toxic, difficult to administer, or losing effectiveness. The RNA-editing machinery offers a potential drug target that would not affect human cells, but drug design requires knowing exactly how the machine grabs, cuts, and re-joins RNA molecules. This project will use structural biology, biochemistry, and cell-based experiments to map how the core editosome recognises RNA, how guide RNAs direct editing, and how the cell decides whether to stabilise or degrade edited transcripts. If successful, the work will provide atomic-level blueprints for designing drugs that jam the editing machine. It will also illuminate a broader biological puzzle: how cells use short stretches of the nucleotide uridine to tag RNA for processing—a mechanism that also operates in mammalian gene regulation. This is fundamental science with a clear translational path.

View original technical description
Trypanosomatid parasites constitute a huge health and economic burden in developing countries. These organisms edit essential mitochondrial mRNAs using a unique and fascinating RNA-editing mechanism not present in mammals. As such, the RNA-editing machinery is an attractive target for development of antiparasitic drugs. During mRNA editing, “guide” RNAs direct uridine insertion or deletion within a large protein complex: the core editosome. How RNA substrates are recognised by this molecular machine is poorly understood. Remarkably, no RNA is stably associated with the editosome; instead peripheral proteins and their RNA complexes ensure efficient editing. These ancillary complexes generate guide RNAs, anneal them to pre-mRNAs, enable multiple rounds of mRNA editing within the core editosome and conduct post-editing maturation of mRNA. Using combined structural, biochemical and cell-based approaches we will address key mechanistic questions for trypanosome mRNA editing. We will elucidate the structural basis for strand-specific mRNA cleavage and mRNA re-ligation; how oligouridylylated transcripts are recognised and how these sequences might direct transcript stabilisation or degradation. This work will both illuminate how RNA substrates are recognised on core editing enzymes to facilitate drug discovery and inform our understanding of oligouridylylation-directed RNA processing, which important in mammalian gene expression.

View the original record at the funder ↗

Researchers

Atlanta Cook (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

RNA Editing Ligase 1 as a Novel Drug Target for Diseases Caused by Trypanosomatid Parasites
Mitochondrial biogenesis and function in trypanosomes
(AFS) RNA Editing Ligase 1 and F1-ATPase as novel drug targets for veterinary diseases caused by trypanosomatid parasites
An integrated screening strategy to develop inhibitors of Trypanosoma brucei RNA editing ligase 1.
Deciphering mechanisms of epigenetic regulation in Trypanosoma brucei, an evolutionarily distinct human pathogen.

Original classification

Senior Research Fellowship Basic

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.